Literature DB >> 21606202

The angiotensin-(1-7)/Mas receptor axis is expressed in sinoatrial node cells of rats.

Anderson J Ferreira1, Patrícia L Moraes, Giselle Foureaux, Alexandre B Andrade, Robson A S Santos, Alvair P Almeida.   

Abstract

The authors' previous studies have indicated that angiotensin(Ang)-(1-7) protects the heart against reperfusion arrhythmias. The aim of this study was to determine whether a functional angiotensin-converting enzyme2 (ACE2)/Ang-(1-7)/Mas receptor axis is present in the sinoatrial node (SAN) of Wistar rats. SAN cells were identified by Masson's trichrome staining, HCN4 expression, and lack of connexin43 expression. Immunohistochemistry technique was used to detect the expression of ACE2, Ang-(1-7), and Mas in the SAN. To evaluate the role of this axis in the SAN function, atrial tachyarrhythmias (ATs) were induced in isolated rat atria perfused with Krebs-Ringer solution (KRS) alone (control) or KRS containing Ang-(1-7). The specific Mas antagonist, A-779, was used to evaluate the role of Mas in the Ang-(1-7) effects. The findings showed that all components of the ACE2/Ang-(1-7)/Mas branch are present in the SAN of rats. Importantly, it was found that this axis is functional because perfusion of atria with Ang-(1-7) significantly reduced the duration of ATs. Additionally, this anti-arrhythmogenic effect was attenuated by A-779. No significant changes were observed in heart rate, contractile tension, or ±dT/dt. These observations demonstrate that the ACE2/Ang-(1-7)/Mas axis is expressed in SAN cells of rats. They provide the morphological support to the anti-arrhythmogenic effect of Ang-(1-7).
© The Author(s) 2011

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21606202      PMCID: PMC3261602          DOI: 10.1369/0022155411411712

Source DB:  PubMed          Journal:  J Histochem Cytochem        ISSN: 0022-1554            Impact factor:   2.479


  25 in total

1.  Expression of an angiotensin-(1-7)-producing fusion protein produces cardioprotective effects in rats.

Authors:  Robson A S Santos; Anderson J Ferreira; Ana Paula Nadu; Aline N G Braga; Alvair Pinto de Almeida; Maria José Campagnole-Santos; Ovidiu Baltatu; Radu Iliescu; Timothy L Reudelhuber; Michael Bader
Journal:  Physiol Genomics       Date:  2004-05-19       Impact factor: 3.107

2.  Organisation of the mouse sinoatrial node: structure and expression of HCN channels.

Authors:  Jie Liu; Halina Dobrzynski; Joseph Yanni; Mark R Boyett; Ming Lei
Journal:  Cardiovasc Res       Date:  2006-11-15       Impact factor: 10.787

3.  Beneficial versus harmful effects of Angiotensin (1-7) on impulse propagation and cardiac arrhythmias in the failing heart.

Authors:  Walmor C De Mello; Carlos M Ferrario; Jewell A Jessup
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2007-06       Impact factor: 1.636

4.  Effect of angiotensin-(1-7) on reperfusion arrhythmias in isolated rat hearts.

Authors:  L A Neves; A P Almeida; M C Khosla; M J Campagnole-Santos; R A Santos
Journal:  Braz J Med Biol Res       Date:  1997-06       Impact factor: 2.590

5.  The nonpeptide angiotensin-(1-7) receptor Mas agonist AVE-0991 attenuates heart failure induced by myocardial infarction.

Authors:  Anderson J Ferreira; Bruno A Jacoby; Cícero A A Araújo; Filipe A F F Macedo; Gerluza A B Silva; Alvair P Almeida; Marcelo V Caliari; Robson A S Santos
Journal:  Am J Physiol Heart Circ Physiol       Date:  2006-10-20       Impact factor: 4.733

6.  Impairment of in vitro and in vivo heart function in angiotensin-(1-7) receptor MAS knockout mice.

Authors:  Robson A S Santos; Carlos H Castro; Elisandra Gava; Sérgio V B Pinheiro; Alvair P Almeida; Renata Dutra de Paula; Jader S Cruz; Anderson S Ramos; Kaleizu T Rosa; Maria C Irigoyen; Michael Bader; Natalia Alenina; Gregory T Kitten; Anderson J Ferreira
Journal:  Hypertension       Date:  2006-03-27       Impact factor: 10.190

7.  Angiotensin (1-7) re-establishes impulse conduction in cardiac muscle during ischaemia-reperfusion. The role of the sodium pump.

Authors:  Walmor C De Mello
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2004-12       Impact factor: 1.636

8.  Angiotensin-(1-7) prevents development of severe hypertension and end-organ damage in spontaneously hypertensive rats treated with L-NAME.

Authors:  Ibrahim F Benter; Mariam H M Yousif; J T Anim; C Cojocel; D I Diz
Journal:  Am J Physiol Heart Circ Physiol       Date:  2006-02       Impact factor: 4.733

9.  Cholinergic-adrenergic antagonism in the induction of tachyarrhythmia by electrical stimulation in isolated rat atria.

Authors:  Nivaldo Zafalon; José W M Bassani; Rosana A Bassani
Journal:  J Mol Cell Cardiol       Date:  2004-07       Impact factor: 5.000

10.  Heart block, ventricular tachycardia, and sudden death in ACE2 transgenic mice with downregulated connexins.

Authors:  Mary Donoghue; Hiroko Wakimoto; Colin T Maguire; Susan Acton; Paul Hales; Nancy Stagliano; Victoria Fairchild-Huntress; Jian Xu; John N Lorenz; Vivek Kadambi; Charles I Berul; Roger E Breitbart
Journal:  J Mol Cell Cardiol       Date:  2003-09       Impact factor: 5.000

View more
  17 in total

Review 1.  International Union of Basic and Clinical Pharmacology. XCIX. Angiotensin Receptors: Interpreters of Pathophysiological Angiotensinergic Stimuli [corrected].

Authors:  Sadashiva S Karnik; Hamiyet Unal; Jacqueline R Kemp; Kalyan C Tirupula; Satoru Eguchi; Patrick M L Vanderheyden; Walter G Thomas
Journal:  Pharmacol Rev       Date:  2015-10       Impact factor: 25.468

2.  Chronic activation of endogenous angiotensin-converting enzyme 2 protects diabetic rats from cardiovascular autonomic dysfunction.

Authors:  Tatiane M Murça; Tatiane C S Almeida; Mohan K Raizada; Anderson J Ferreira
Journal:  Exp Physiol       Date:  2012-01-27       Impact factor: 2.969

3.  Angiotensin-(1-7): Translational Avenues in Cardiovascular Control.

Authors:  Daniela Medina; Amy C Arnold
Journal:  Am J Hypertens       Date:  2019-11-15       Impact factor: 2.689

Review 4.  The ACE2/Angiotensin-(1-7)/MAS Axis of the Renin-Angiotensin System: Focus on Angiotensin-(1-7).

Authors:  Robson Augusto Souza Santos; Walkyria Oliveira Sampaio; Andreia C Alzamora; Daisy Motta-Santos; Natalia Alenina; Michael Bader; Maria Jose Campagnole-Santos
Journal:  Physiol Rev       Date:  2018-01-01       Impact factor: 37.312

5.  Clinical Manifestations of COVID-19.

Authors:  Mahsa Eskian; Nima Rezaei
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

6.  Severe Sinus Bradycardia: An Unusual Cardiac Manifestation of COVID-19.

Authors:  Mohammed Ali; Abdalaziz Awadelkarim; Patrick Bishop; Rashid Alhusain; Omeralfaroug Adam; Ahmed Subahi; Adel Elmoghrabi; Luis Afonso
Journal:  J Investig Med High Impact Case Rep       Date:  2021 Jan-Dec

7.  New cardiovascular and pulmonary therapeutic strategies based on the Angiotensin-converting enzyme 2/angiotensin-(1-7)/mas receptor axis.

Authors:  Anderson J Ferreira; Tatiane M Murça; Rodrigo A Fraga-Silva; Carlos Henrique Castro; Mohan K Raizada; Robson A S Santos
Journal:  Int J Hypertens       Date:  2012-01-26       Impact factor: 2.420

8.  Association of exercise training and angiotensin-converting enzyme 2 activator improves baroreflex sensitivity of spontaneously hypertensive rats.

Authors:  P R Lopes; M C S Moreira; S M Marques; I S J Pinto; L M Macedo; C C Silva; A H Freiria-Oliveira; A C S Rebelo; A A S Reis; D A Rosa; M L Ferreira-Neto; C H Castro; G R Pedrino
Journal:  Braz J Med Biol Res       Date:  2016-08-01       Impact factor: 2.590

Review 9.  Review article: the pathophysiological roles of the renin-angiotensin system in the gastrointestinal tract.

Authors:  M Garg; P W Angus; L M Burrell; C Herath; P R Gibson; J S Lubel
Journal:  Aliment Pharmacol Ther       Date:  2012-01-05       Impact factor: 8.171

Review 10.  Three key proteases--angiotensin-I-converting enzyme (ACE), ACE2 and renin--within and beyond the renin-angiotensin system.

Authors:  Cuie Guang; Robert D Phillips; Bo Jiang; Franco Milani
Journal:  Arch Cardiovasc Dis       Date:  2012-06-15       Impact factor: 2.340

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.